VanEck Biotech ETF BBH

Medalist Rating as of | See VanEck Investment Hub

Morningstar’s Analysis BBH

Will BBH outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

VanEck Biotech ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BBH

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 72.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amgen Inc

15.75 77M
Healthcare

Gilead Sciences Inc

13.15 64M
Healthcare

Vertex Pharmaceuticals Inc

8.20 40M
Healthcare

Regeneron Pharmaceuticals Inc

6.49 32M
Healthcare

Moderna Inc

6.05 30M
Healthcare

Natera Inc

5.33 26M
Healthcare

argenx SE ADR

4.58 22M
Healthcare

IQVIA Holdings Inc

4.46 22M
Healthcare

Revolution Medicines Inc Ordinary Shares

4.21 21M
Healthcare

Illumina Inc

4.04 20M
Healthcare

Sponsor Center